KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Other Non-Current Liabilities (2016 - 2025)

Precigen (PGEN) has disclosed Other Non-Current Liabilities for 11 consecutive years, with $50.5 million as the latest value for Q4 2024.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $50.5 million in Q4 2024 year-over-year; TTM through Dec 2024 was $50.5 million, a N/A change, with the full-year FY2024 number at $50.5 million, changed N/A from a year prior.
  • Other Non-Current Liabilities was $50.5 million for Q4 2024 at Precigen, up from $50000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $50.5 million in Q4 2024 to a low of $50000.0 in Q2 2021.
  • A 4-year average of $5.7 million and a median of $100000.0 in 2020 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: plummeted 54.95% in 2020, then crashed 50.0% in 2021.
  • Precigen's Other Non-Current Liabilities stood at $100000.0 in 2020, then plummeted by 50.0% to $50000.0 in 2021, then changed by 0.0% to $50000.0 in 2022, then skyrocketed by 100974.0% to $50.5 million in 2024.
  • Per Business Quant, the three most recent readings for PGEN's Other Non-Current Liabilities are $50.5 million (Q4 2024), $50000.0 (Q1 2022), and $50000.0 (Q4 2021).